Showing results (1-10 of 831) with videos related to
Sort By:
Pageof 84
Best Practice & Research. Clinical Haematology|July 20, 2005
Cytokines and signal transductionTeru Hideshima, Klaus Podar, Dharminder Chauhan, et al.Expert Opinion on Therapeutic Targets|June 7, 2005
Targeting signalling pathways for the treatment of multiple myelomaKlaus Podar, Teru Hideshima, Dharminder Chauhan, et al.Best Practice & Research. Clinical Haematology|December 12, 2007
The malignant clone and the bone-marrow environmentKlaus Podar, Paul G Richardson, Teru Hideshima, et al.Advances in Experimental Medicine and Biology|April 29, 2008
Targeting proteasomes as therapy in multiple myelomaDharminder Chauhan, Teru Hideshima, Kenneth C AndersonInternational Journal of Hematology|September 5, 2003
Apoptotic signaling in multiple myeloma: therapeutic implicationsDharminder Chauhan, Teru Hideshima, Kenneth C AndersonAnnual Review of Pharmacology and Toxicology|April 12, 2005
Proteasome inhibition in multiple myeloma: therapeutic implicationDharminder Chauhan, Teru Hideshima, Kenneth C AndersonCancer Research|October 16, 2003
Blockade of Hsp27 overcomes Bortezomib/proteasome inhibitor PS-341 resistance in lymphoma cellsDharminder Chauhan, Guilan Li, Reshma Shringarpure, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2005
Identification and validation of novel therapeutic targets for multiple myelomaTeru Hideshima, Dharminder Chauhan, Paul Richardson, et al.Oncogene|September 19, 2003
Superoxide-dependent and -independent mitochondrial signaling during apoptosis in multiple myeloma cellsDharminder Chauhan, Guilan Li, Martin Sattler, et al.The Journal of Biological Chemistry|April 1, 2003
JNK-dependent release of mitochondrial protein, Smac, during apoptosis in multiple myeloma (MM) cellsDharminder Chauhan, Guilan Li, Teru Hideshima, et al.Pageof 84